DadFinStart your free weekRepligen Corporation (RGEN) stock score
$173.88 ▲ +6.13% today
Repligen Corporation (RGEN) is a Medical Instruments & Supplies company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 76.5 out of 100 on the Dad Score, a good reading that places the business ahead of 76% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #210 of 974. Its strongest axes are quality, growth and price action; its weakest is valuation.
Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →
The eight axes
Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.
Key numbers
What subscribers see on RGEN
- Value Score: is the price right for this business, the score the Value book is selected on.
- Trader Score: is it set up to move, refreshed every 15 minutes in the session.
- The full eight-axis breakdown, every input and its percentile.
- SEC filings, insider buying, earnings history and peers side by side.
- Whether it is in this week's published books, with the receipts.
Medical Instruments & Supplies peers
| Stock | Company | Dad Score | Band |
|---|---|---|---|
| ISRG | Intuitive Surgical, Inc. | 87.0 | strong |
| BDX | Becton, Dickinson and Company | 69.8 | middling |
| MDLN | Medline Inc. | 98.2 | strong |
| ALC | Alcon Inc. | 64.6 | middling |
| RMD | ResMed Inc. | 94.3 | strong |
| WST | West Pharmaceutical Services, Inc. | 90.1 | strong |
| SOLV | Solventum Corporation | 71.9 | good |
| BAX | Baxter International Inc. | 40.5 | middling |
Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.